Variant report

Variant	nsv980947
Chromosome Location	chr5:147571596-147583858
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr5:147571419-147571641	Hela-S3	cervix:	n/a	chr5:147571486-147571499 chr5:147571486-147571497
2	CEBPB	chr5:147572321-147572641	Hela-S3	cervix:	n/a	n/a
3	CTCF	chr5:147574277-147574348	GM13976	blood:	n/a	n/a
4	E2F4	chr5:147572472-147572735	MCF10A-Er-Src	breast:	n/a	n/a
5	EP300	chr5:147572345-147572646	Hela-S3	cervix:	n/a	n/a
6	FOS	chr5:147572241-147572903	MCF10A-Er-Src	breast:	n/a	n/a
7	FOS	chr5:147572303-147572584	MCF10A-Er-Src	breast:	n/a	n/a
8	FOS	chr5:147573943-147574082	MCF10A-Er-Src	breast:	n/a	n/a
9	FOS	chr5:147582138-147582458	MCF10A-Er-Src	breast:	n/a	n/a
10	FOS	chr5:147582104-147582459	MCF10A-Er-Src	breast:	n/a	n/a
11	FOS	chr5:147572241-147572817	MCF10A-Er-Src	breast:	n/a	n/a
12	FOS	chr5:147572266-147572658	MCF10A-Er-Src	breast:	n/a	n/a
13	FOS	chr5:147582130-147582470	MCF10A-Er-Src	breast:	n/a	n/a
14	KAP1	chr5:147576474-147576724	K562	blood:	n/a	n/a
15	MAFF	chr5:147579151-147579449	HepG2	liver:	n/a	chr5:147579292-147579310
16	MAFK	chr5:147575608-147575669	IMR90	lung:	n/a	n/a
17	MAFK	chr5:147583779-147584032	HepG2	liver:	n/a	chr5:147583875-147583890
18	MAFK	chr5:147583741-147584025	HepG2	liver:	n/a	chr5:147583875-147583890
19	MAFK	chr5:147579145-147579466	HepG2	liver:	n/a	chr5:147579293-147579307 chr5:147579294-147579310 chr5:147579294-147579305 chr5:147579294-147579309 chr5:147579294-147579305 chr5:147579295-147579306
20	MAFK	chr5:147575506-147575715	HepG2	liver:	n/a	n/a
21	MAFK	chr5:147575439-147575650	HepG2	liver:	n/a	n/a
22	MAFK	chr5:147581165-147581416	HepG2	liver:	n/a	n/a
23	MAFK	chr5:147579133-147579397	HepG2	liver:	n/a	chr5:147579293-147579307 chr5:147579294-147579310 chr5:147579294-147579305 chr5:147579294-147579309 chr5:147579294-147579305 chr5:147579295-147579306
24	MYC	chr5:147576206-147576367	K562	blood:	n/a	n/a
25	MYC	chr5:147573889-147574021	MCF10A-Er-Src	breast:	n/a	n/a
26	MYC	chr5:147572121-147572177	MCF-7	breast:	n/a	n/a
27	MYC	chr5:147572332-147572681	MCF10A-Er-Src	breast:	n/a	n/a
28	POLR2A	chr5:147576633-147576787	MCF10A-Er-Src	breast:	n/a	n/a
29	POLR2A	chr5:147580047-147580049	MCF10A-Er-Src	breast:	n/a	n/a
30	POLR2A	chr5:147572276-147572476	MCF10A-Er-Src	breast:	n/a	n/a
31	PRDM1	chr5:147576651-147576664	Hela-S3	cervix:	n/a	n/a
32	RCOR1	chr5:147572427-147572646	Hela-S3	cervix:	n/a	n/a
33	STAT3	chr5:147572225-147572872	MCF10A-Er-Src	breast:	n/a	chr5:147572399-147572410
34	STAT3	chr5:147572510-147572684	MCF10A-Er-Src	breast:	n/a	n/a
35	STAT3	chr5:147582206-147582406	MCF10A-Er-Src	breast:	n/a	n/a
36	STAT3	chr5:147571435-147571635	MCF10A-Er-Src	breast:	n/a	chr5:147571528-147571536
37	STAT3	chr5:147572239-147572886	MCF10A-Er-Src	breast:	n/a	chr5:147572399-147572410
38	STAT3	chr5:147575762-147575784	MCF10A-Er-Src	breast:	n/a	n/a
39	STAT3	chr5:147579616-147579774	MCF10A-Er-Src	breast:	n/a	n/a
40	STAT3	chr5:147572210-147572868	MCF10A-Er-Src	breast:	n/a	chr5:147572399-147572410
41	STAT3	chr5:147571614-147571615	MCF10A-Er-Src	breast:	n/a	n/a
42	TBL1XR1	chr5:147582327-147582332	K562	blood:	n/a	n/a
43	TCF7L2	chr5:147572399-147572920	Hela-S3	cervix:	n/a	chr5:147572806-147572815 chr5:147572803-147572819 chr5:147572803-147572819 chr5:147572805-147572815 chr5:147572804-147572818 chr5:147572808-147572815 chr5:147572807-147572816

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:147582460-147582510	HRPEpiC	eye:	n/a
2	chr5:147582460-147582510	PFSK-1	brain:	n/a
3	chr5:147582460-147582510	T-47D	breast:	n/a
4	chr5:147582460-147582510	AG10803	skin:	n/a
5	chr5:147582460-147582510	ovcar-3	ovarian:	n/a
6	chr5:147582460-147582510	AG04450	lung:	fetal
7	chr5:147582460-147582510	H1-hESC	embryonic stem cell:	embryo
8	chr5:147582460-147582510	HCM	heart:	n/a
9	chr5:147582460-147582510	HMEC	breast:	n/a
10	chr5:147582460-147582510	AG09309	skin:	n/a
11	chr5:147582460-147582510	HIPEpiC	eye:	n/a
12	chr5:147582460-147582510	GM12891	blood:	n/a
13	chr5:147582460-147582510	Jurkat	blood:	n/a
14	chr5:147582460-147582510	HCF	heart:	n/a
15	chr5:147582460-147582510	GM06990	blood:	n/a
16	chr5:147582460-147582510	SKMC	muscle:	n/a
17	chr5:147582460-147582510	AG09319	gingival:	n/a
18	chr5:147582460-147582510	CMK	blood:	n/a
19	chr5:147582460-147582510	NHBE	bronchial:	n/a
20	chr5:147582460-147582510	K562	blood:	n/a
21	chr5:147582460-147582510	MCF10A-Er-Src	breast:	n/a
22	chr5:147582460-147582510	AoSMC	blood vessel:	n/a
23	chr5:147582460-147582510	HRCEpiC	kidney:	n/a
24	chr5:147582460-147582510	RPTEC	kidney:	n/a
25	chr5:147582460-147582510	IMR90	lung:	fetal
26	chr5:147582460-147582510	NB4	blood:	n/a
27	chr5:147582460-147582510	SAEC	small airway:	n/a
28	chr5:147582460-147582510	ECC-1	luminal epithelium:	n/a
29	chr5:147582460-147582510	GM19239	blood:	n/a
30	chr5:147582460-147582510	MCF-7	breast:	n/a
31	chr5:147582460-147582510	Hela-S3	cervix:	n/a
32	chr5:147582460-147582510	SK-N-MC	brain:	n/a
33	chr5:147582460-147582510	PANC-1	pancreas:	n/a
34	chr5:147582460-147582510	LNCaP	prostate:	n/a
35	chr5:147582460-147582510	Caco-2	colon:	n/a
36	chr5:147582460-147582510	A549	lung:	n/a
37	chr5:147582460-147582510	BE2_C	brain:	n/a
38	chr5:147582460-147582510	HEEpiC	esophagus:	n/a
39	chr5:147582460-147582510	HepG2	liver:	n/a
40	chr5:147582460-147582510	U87	brain:	n/a
41	chr5:147582460-147582510	HPAEpiC	pulmonary alveolar:	n/a
42	chr5:147582460-147582510	HCT-116	colon:	n/a
43	chr5:147582460-147582510	BJ	skin:	n/a
44	chr5:147582460-147582510	HNPCEpiC	eye:	n/a
45	chr5:147582460-147582510	HL-60	blood:	n/a
46	chr5:147582460-147582510	HEK293	kidney:	embryo
47	chr5:147582460-147582510	HUVEC	blood vessel:	n/a
48	chr5:147582460-147582510	HRE	kidney:	n/a
49	chr5:147582460-147582510	GM12892	blood:	n/a
50	chr5:147582460-147582510	HAEpiC	amniotic membrane:	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:147575494..147576358-chr5:147640450..147641333,4	MCF-7	breast:
2	chr5:147575500..147576422-chr5:147685184..147686083,4	MCF-7	breast:
3	chr5:147575500..147576238-chr5:147685562..147686083,2	MCF-7	breast:
4	chr5:147575494..147576358-chr5:147640450..147641242,3	MCF-7	breast:
5	chr5:147569510..147572351-chr5:147602489..147604362,3	K562	blood:
6	chr5:147579906..147582066-chr5:147584142..147586764,3	K562	blood:

Variant related genes	Relation type
SPINK6	TF binding region
SPINK6	CpG island

Extended variants
information (count: 488 )
Associated
traits (count: 76 )

Variant overlapped rSNPs/rCNVs (count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs564000392	chr5:147571613-147571614	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs531602183	chr5:147571622-147571623	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs189317965	chr5:147571625-147571626	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs34506706	chr5:147571674-147571675	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs28701955	chr5:147571755-147571756	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
6	rs180923704	chr5:147571765-147571766	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs566163747	chr5:147571833-147571834	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs539987112	chr5:147571861-147571862	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs148893988	chr5:147571885-147571886	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs67008048	chr5:147571886-147571887	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs397702477	chr5:147571890-147571891	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs201341639	chr5:147571891-147571892	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs201702398	chr5:147571893-147571894	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs142399961	chr5:147571914-147571915	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs144598857	chr5:147571948-147571949	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs28459444	chr5:147571949-147571950	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs149424355	chr5:147571957-147571958	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs28406596	chr5:147571984-147571985	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
19	rs28667181	chr5:147571993-147571994	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs55941580	chr5:147572020-147572021	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs556556103	chr5:147572022-147572023	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs11454373	chr5:147572023-147572024	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs553798709	chr5:147572051-147572052	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs7726411	chr5:147572052-147572053	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs374772400	chr5:147572055-147572056	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs545939230	chr5:147572077-147572078	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs557679867	chr5:147572083-147572084	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs565788364	chr5:147572102-147572103	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs575922952	chr5:147572115-147572116	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs543446390	chr5:147572164-147572165	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs118106269	chr5:147572172-147572173	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs573762558	chr5:147572177-147572178	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs372846452	chr5:147572186-147572187	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs35898773	chr5:147572232-147572233	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs11745313	chr5:147572263-147572264	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs541181148	chr5:147572271-147572272	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs368773844	chr5:147572305-147572306	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs112337027	chr5:147572352-147572353	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs189488167	chr5:147572364-147572365	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs373457641	chr5:147572383-147572384	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs11951981	chr5:147572454-147572455	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs6891761	chr5:147572495-147572496	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs144394285	chr5:147572496-147572497	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs67501048	chr5:147572497-147572498	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs3036831	chr5:147572499-147572500	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs531212073	chr5:147572539-147572540	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs7717699	chr5:147572546-147572547	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs4498243	chr5:147572627-147572628	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
49	rs574209525	chr5:147572645-147572646	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs535390886	chr5:147572765-147572766	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:76)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute myeloid leukemia	21251322	CNVD
lymphocytic leukemia	21291569	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	19377443	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18194544	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Renal cell carcinoma	18592004	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	17053054	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Hyperekplexia	16941485	CNVD
Myelofibrosis	22110671	CNVD
Crohn''s disease	20877625	CNVD
T-cell lymphomas	19863542	CNVD
Breast cancer	17603634	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:69 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:147567200-147571800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr5:147567200-147572000	Weak transcription	Primary monocytes fromperipheralblood	blood
3	chr5:147567200-147572200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr5:147567200-147572200	Weak transcription	Hela-S3	cervix
5	chr5:147567400-147572000	Weak transcription	Monocytes-CD14+_RO01746	blood
6	chr5:147571400-147572000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
7	chr5:147571400-147572800	Enhancers	HMEC	breast
8	chr5:147571800-147572200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
9	chr5:147572000-147572800	Enhancers	Primary monocytes fromperipheralblood	blood
10	chr5:147572000-147572800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
11	chr5:147572000-147572800	Enhancers	Monocytes-CD14+_RO01746	blood
12	chr5:147572200-147572600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr5:147572200-147572800	Enhancers	NHEK	skin
14	chr5:147572200-147573200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr5:147572200-147573200	Enhancers	Hela-S3	cervix
16	chr5:147572200-147582000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
17	chr5:147572800-147573400	Enhancers	Rectal Smooth Muscle	rectum
18	chr5:147572800-147575600	Weak transcription	NHEK	skin
19	chr5:147572800-147575800	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr5:147573200-147584000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr5:147575600-147576000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr5:147575600-147576200	Enhancers	NHEK	skin
23	chr5:147575800-147576600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr5:147576000-147581000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr5:147576200-147581400	Weak transcription	NHEK	skin
26	chr5:147576600-147582400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
27	chr5:147578800-147579400	Enhancers	iPS-15b Cell Line	embryonic stem cell
28	chr5:147578800-147579400	Enhancers	iPS-18 Cell Line	embryonic stem cell
29	chr5:147578800-147579600	Enhancers	HUES48 Cell Line	embryonic stem cell
30	chr5:147578800-147579800	Enhancers	Fetal Intestine Large	intestine
31	chr5:147579000-147579400	Enhancers	H1 Cell Line	embryonic stem cell
32	chr5:147579000-147579600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr5:147579200-147579400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr5:147579200-147579600	Enhancers	H9 Cell Line	embryonic stem cell
35	chr5:147579200-147579800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
36	chr5:147579600-147583800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
37	chr5:147579800-147584800	Weak transcription	Fetal Intestine Large	intestine
38	chr5:147580000-147580600	Weak transcription	Monocytes-CD14+_RO01746	blood
39	chr5:147580400-147580800	Enhancers	Primary neutrophils fromperipheralblood	blood
40	chr5:147580600-147580800	Enhancers	Monocytes-CD14+_RO01746	blood
41	chr5:147580800-147581000	Enhancers	Primary monocytes fromperipheralblood	blood
42	chr5:147580800-147581200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
43	chr5:147580800-147581200	Active TSS	Primary hematopoietic stem cells	blood
44	chr5:147580800-147581400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
45	chr5:147581000-147581400	Active TSS	Primary monocytes fromperipheralblood	blood
46	chr5:147581000-147581600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
47	chr5:147581200-147581600	Enhancers	Primary neutrophils fromperipheralblood	blood
48	chr5:147581400-147581600	Enhancers	Monocytes-CD14+_RO01746	blood
49	chr5:147581400-147581800	Enhancers	Primary monocytes fromperipheralblood	blood
50	chr5:147581400-147582400	Enhancers	NHEK	skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links